Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

HIV Infections 4Acquired Immunodeficiency Syndrome 4Sarcoma, Kaposi 3Lymphoma 2Head and Neck Neoplasms 2Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Skin Neoplasms 1Pancreatic Neoplasms 1Nervous System Neoplasms 1Neoplasm Metastasis 1Melanoma 1Lymphoma, Non-Hodgkin 1Hodgkin Disease 1Hematologic Diseases 1Carcinoma, Squamous Cell 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

veliparib 1sargramostim 1etoposide phosphate 1Vincristine 1Sunitinib 1Methotrexate 1Leucovorin 1Etoposide 1Doxorubicin 1Dexamethasone 1Cytarabine 1Cyclophosphamide 1Bleomycin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Nervous System Neoplasms × Bleomycin × Clear all
NCT00000689 2021-11-02

Phase I Trial of mBACOD and Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in AIDS-Associated Large Cell, Immunoblastic, and Small Non-cleaved Lymphoma

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 1 Completed
18 enrolled
Lymphoid

Acquired Immunodeficiency Syndrome, Lymphoma, Non-Hodgkin, Nervous System Neoplasms, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡